Miha Biotech
Miha Biotech is dedicated to elevating burn care worldwide by harnessing nature's healing properties from the ocean. Their innovative products, derived from Canadian seaweed, aim to provide eco-friendly, scar-free, and painless wound healing solutions. The company is actively involved in research, development, and collaborations to advance sustainable ocean technology and improve health outcomes.
Industries
Nr. of Employees
small (1-50)
Miha Biotech
Products
Seaweed-collagen moisture bandage
A moisture-retaining bandage composed primarily of seaweed-derived biomaterials combined with collagen, formulated to be hypoallergenic and suitable for sensitive skin; designed for burn wound relief and prevention of blistering.
Seaweed-collagen moisture bandage
A moisture-retaining bandage composed primarily of seaweed-derived biomaterials combined with collagen, formulated to be hypoallergenic and suitable for sensitive skin; designed for burn wound relief and prevention of blistering.
Services
Partnerships and collaborative R&D with research centres and consortia to advance biomaterials and product development; participation in incubator and grant programs.
Partnerships and collaborative R&D with research centres and consortia to advance biomaterials and product development; participation in incubator and grant programs.
Expertise Areas
- Wound-care biomaterial development
- Burn treatment product design
- Marine-sourced biomaterials
- Material science for medical dressings
Key Technologies
- Seaweed-derived biomaterials
- Collagen-based topical formulations
- Moisture-retaining hydrogel dressing technology
- Microstructured adhesive surfaces
News & Updates
In April 2024, Miha Biotech received a $10,000 grant from the Science Impact program in Quebec to advance their R&D efforts.
In March 2024, Miha Biotech was awarded the $3,000 Ocean Challenge: Boost fund to advance sustainable ocean technology in Canada.
In August 2023, Miha Biotech received a $15,000 grant from CRIBIQ to collaborate with experts at the Marine Biotechnology Centre.
In June 2023, Miha Biotech was selected for the Lab2Market Health Stream 2023 incubator cohort, receiving a non-dilutive investment of $15,000.
In July 2022, supported by V1 Studio, BioHub, and Concordia University, the project 'BioCure' was launched with a total grant of $75,000.
In April 2024, Miha Biotech received a $10,000 grant from the Science Impact program in Quebec to advance their R&D efforts.
In March 2024, Miha Biotech was awarded the $3,000 Ocean Challenge: Boost fund to advance sustainable ocean technology in Canada.
In August 2023, Miha Biotech received a $15,000 grant from CRIBIQ to collaborate with experts at the Marine Biotechnology Centre.
In June 2023, Miha Biotech was selected for the Lab2Market Health Stream 2023 incubator cohort, receiving a non-dilutive investment of $15,000.
In July 2022, supported by V1 Studio, BioHub, and Concordia University, the project 'BioCure' was launched with a total grant of $75,000.